Mouwasat Medical Services Company (TADAWUL:4002)
Saudi Arabia · Delayed Price · Currency is SAR 65.50
+0.20 (0.31%)
Sep 3, 2026, 3:19 PM AST
TADAWUL:4002 Ratios and Metrics
Market cap in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 13,100 | 13,330 | 17,020 | 22,360 | 20,900 | 17,380 | |
Market Cap Growth | -10.64% | -21.68% | -23.88% | 6.99% | 20.25% | 25.94% |
Enterprise Value | 14,269 | 13,968 | 17,693 | 23,174 | 21,901 | 18,178 |
Last Close Price | 65.50 | 65.55 | 80.39 | 103.96 | 96.00 | 78.94 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 15.40 | 16.22 | 26.36 | 34.00 | 34.87 | 30.06 |
Forward PE | 15.02 | 16.67 | 20.61 | 30.17 | 29.27 | 26.82 |
PS Ratio | 3.88 | 4.14 | 5.91 | 8.27 | 8.95 | 8.11 |
PB Ratio | 3.19 | 3.40 | 4.58 | 6.53 | 6.79 | 6.43 |
P/TBV Ratio | 3.34 | 3.57 | 4.82 | 6.90 | 7.23 | 6.76 |
P/FCF Ratio | 20.01 | 17.36 | 20.57 | 41.66 | 50.42 | 48.83 |
P/OCF Ratio | 11.29 | 11.32 | 13.55 | 27.48 | 29.55 | 25.45 |
PEG Ratio | 3.00 | 1.67 | 1.32 | 2.22 | 2.25 | 1.92 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 4.23 | 4.34 | 6.15 | 8.57 | 9.38 | 8.48 |
EV/EBITDA Ratio | 12.35 | 12.51 | 18.52 | 23.78 | 25.61 | 23.49 |
EV/EBIT Ratio | 15.88 | 15.90 | 24.45 | 30.63 | 32.57 | 29.23 |
EV/FCF Ratio | 21.80 | 18.19 | 21.38 | 43.18 | 52.84 | 51.08 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.29 | 0.25 | 0.21 | 0.23 | 0.29 | 0.31 |
Debt / EBITDA Ratio | 1.02 | 0.88 | 0.79 | 0.81 | 1.04 | 1.07 |
Debt / FCF Ratio | 1.81 | 1.29 | 0.92 | 1.47 | 2.15 | 2.33 |
Net Debt / Equity Ratio | 0.25 | 0.13 | 0.07 | 0.19 | 0.21 | 0.21 |
Net Debt / EBITDA Ratio | 0.89 | 0.44 | 0.26 | 0.66 | 0.75 | 0.74 |
Net Debt / FCF Ratio | 1.56 | 0.64 | 0.30 | 1.19 | 1.54 | 1.61 |
Asset Turnover | 0.55 | 0.57 | 0.56 | 0.56 | 0.54 | 0.56 |
Inventory Turnover | 7.43 | 8.02 | 7.76 | 7.04 | 6.40 | 6.24 |
Quick Ratio | 1.19 | 1.41 | 1.64 | 1.58 | 1.69 | 1.64 |
Current Ratio | 1.51 | 1.74 | 1.99 | 1.95 | 2.05 | 2.06 |
Return on Equity (ROE) | 22.58% | 22.32% | 18.75% | 21.17% | 21.90% | 24.03% |
Return on Assets (ROA) | 9.23% | 9.64% | 8.72% | 9.82% | 9.64% | 10.09% |
Return on Invested Capital (ROIC) | 17.78% | 20.24% | 17.10% | 18.41% | 18.44% | 19.39% |
Return on Capital Employed (ROCE) | 16.70% | 17.60% | 16.00% | 18.30% | 17.30% | 18.20% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 6.49% | 6.17% | 3.79% | 2.94% | 2.87% | 3.33% |
FCF Yield | 5.00% | 5.76% | 4.86% | 2.40% | 1.98% | 2.05% |
Dividend Yield | 3.44% | 3.24% | 2.49% | 1.68% | 1.56% | 1.74% |
Payout Ratio | 49.98% | 72.99% | 54.20% | 45.61% | 45.89% | 43.24% |
Total Shareholder Return | 3.44% | 3.24% | 2.49% | 1.68% | 1.56% | 1.74% |